Concepedia

Adam S. Lazorchak

AS

Statistics

Publications

20

Citations

1.8K

H-Index

17

Active since

2004

Affiliations

Yale University(Current)

Duke Medical Center

Curis (United States)

The University of Texas MD Anderson Cancer Center

Duke University Hospital

Adam S. Lazorchak is an author at Yale University specializing in life sciences, immunology, and molecular biology.

Publications per year

2004–2024

20

Publications

20

The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C

Valeria Facchinetti, Weiming Ouyang, Nelyn Soto et al. · The EMBO Journal · 2008 · 511 citations · Full text

, , +12

Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis

Pengda Liu, Wenjian Gan, Hiroyuki Inuzuka et al. · Nature Cell Biology · 2013 · 257 citations · Full text

, , +13

Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion

Yan Lan, Mahmoud Moustafa, Maximilian Knoll et al. · Cancer Cell · 2021 · 190 citations · Full text

, , +17

Human ESC-Derived MSCs Outperform Bone Marrow MSCs in the Treatment of an EAE Model of Multiple Sclerosis

Xiaofang Wang, Erin A. Kimbrel, Kumiko Ijichi et al. · Stem Cell Reports · 2014 · 167 citations · Full text

, , +17

Immune modulatory mesenchymal stem cells derived from human embryonic stem cells through a trophoblast-like stage

Xiaofang Wang, Adam S. Lazorchak, Li Song et al. · Stem Cells · 2015 · 81 citations

, , +17

1–5 of 20